Answers are grounded in this paper and cite their sources.
At least 6.3% of patients with PCD have heterotaxy, and most of those have cardiovascular abnormalities. The prevalence of congenital heart disease with heterotaxy is 200-fold higher in PCD than in the general population (1:50 versus 1:10 000); thus, patients with PCD should have cardiac evaluation. Conversely, mutations in genes that adversely affect both respiratory and embryological nodal cilia are a significant cause of heterotaxy and congenital heart disease, and screening for PCD is indicated in those patients.
No takes yet. Share an insight, caveat, or question.
Kennedy et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: